Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models

J Roh, JA Hill, A Singh, M Valero-Muñoz… - Circulation …, 2022 - Am Heart Assoc
Heart failure with preserved ejection fraction (HFpEF) represents one of the greatest
challenges facing cardiovascular medicine today. Despite being the most common form of …

Fibrosis and heart failure

AM Segura, OH Frazier, LM Buja - Heart failure reviews, 2014 - Springer
The extracellular matrix (ECM) is a living network of proteins that maintains the structural
integrity of the myocardium and allows the transmission of electrical and mechanical forces …

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

P Milliez, X Girerd, PF Plouin, J Blacher… - Journal of the American …, 2005 - jacc.org
Objectives: The aim of this report was to show that the rate of cardiovascular events is
increased in patients with either subtype of primary aldosteronism (PA). Background …

Murine models of heart failure with preserved ejection fraction: a “fishing expedition”

M Valero-Muñoz, W Backman, F Sam - Basic to Translational Science, 2017 - jacc.org
Heart failure with preserved ejection fraction (HFpEF) is characterized by signs and
symptoms of heart failure in the presence of a normal left ventricular ejection fraction …

Cardiac fibrosis: potential therapeutic targets

S Park, NB Nguyen, A Pezhouman, R Ardehali - Translational Research, 2019 - Elsevier
Cardiovascular disease is a leading cause of mortality in the world and is exacerbated by
the presence of cardiac fibrosis, defined by the accumulation of noncontractile extracellular …

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

CG Brilla, RC Funck, H Rupp - Circulation, 2000 - Am Heart Assoc
Background—In arterial hypertension, left ventricular hypertrophy (LVH) includes myocyte
hypertrophy and fibrosis, which leads to LV diastolic dysfunction and, finally, heart failure. In …

Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge

J Gutiérrez-Cuevas, A Sandoval-Rodriguez… - Cells, 2021 - mdpi.com
Obesity is defined as excessive body fat accumulation, and worldwide obesity has nearly
tripled since 1975. Excess of free fatty acids (FFAs) and triglycerides in obese individuals …

Aldosterone induces a vascular inflammatory phenotype in the rat heart

R Rocha, AE Rudolph, GE Frierdich… - American journal …, 2002 - journals.physiology.org
Vascular inflammation was examined as a potential mechanism of aldosterone-mediated
myocardial injury in uninephrectomized rats receiving 1% NaCl-0.3% KCl to drink for 1, 2, or …

Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: from Hans Selye to the present

M Epstein - American journal of nephrology, 2021 - karger.com
Background: A full understanding of the mechanisms of action of aldosterone and its
interaction with the mineralocorticoid receptor (MR) allows a theoretical framework to predict …

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction

B Pitt, G Williams, W Remme, F Martinez… - … Drugs and Therapy, 2001 - Springer
The importance of aldosterone in the pathophysiology of chronic heart failure (HF) has been
established in previous studies [1–4] and is emphasized by the findings of the RALES trial …